|
|
||||||||
Ann Thorac Surg 2005;80:357-358
© 2005 The Society of Thoracic Surgeons
a Division of Thoracic Surgery, SantAndrea Hospital
b Policlinico Umberto I, University of Rome "La Sapienza," Rome, Italy
Accepted for publication February 3, 2004.
* Address reprint requests to Dr Rendina, Division of Thoracic Surgery, Ospedale SantAndrea, via di Grottarossa 1035, 00189 Rome, 00161 Italy; (Email: erinoangelo.rendina{at}tin.it).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
We have extensively employed autologous pericardium for vascular reconstruction in thoracic surgery [15]. Fresh pericardium is however difficult to handle, trim to the appropriate size, and suture to the vascular wall. We have therefore devised a method of intraoperative fixation by glutaraldehyde that makes the autologous pericardial leaflet stiffer and harder and ultimately easier to use. We hereby describe our technique.
| Technique |
|---|
|
|
|---|
|
Among the biological materials currently employed for patch reconstruction our preference refers to the autologous pericardium. The necessity to confer to the fresh autologous pericardial leaflet for adequate stiffness and improved handiness has induced us to devise a method of fixation that can be used intraoperatively and is comparable with those in current use for the preparation of biological heart valves [6].
Once a 0.6% glutaraldehyde-buffered solution has been prepared, the autologous pericardium is harvested anteriorly to the phrenic nerve and the pericardial defect is left open. The pericardial leaflet is dipped in the solution for 10 minutes. The patch is then washed in NaCl 0.9% solution and trimmed to the appropriate size. It is befitting to harvest an amount of tissue larger than the vascular defect because of the shrinkage induced by gluteraldehyde and to tailor the pericardium on the resected part rather than on the vascular defect. The visceral aspect of the pericardium is luminen oriented.
The patch is then secured to the vascular wall by two stay sutures. The inferior stay suture is not tied and is used only to keep the patch in place. It is removed when the suture line reaches its level. Suturing the patch will be considerably simplified at this point because the edges of the fixed pericardium seem stiffer and the leaflet illustrates minimal elastic recoil. It is therefore easier to place the suture bites at the appropriate distance.
The suture is performed using running 5-0 or 6-0 monofilament nonabsorbable material. The suture line has to be carefully checked at the end of the reconstructive procedure, because the PA and SVC are low-pressure vessels and leakage from the suture line may pass unnoticed intraoperatively. Mild anticoagulant therapy (8000 U per day of low weight heparin subcutaneously) is administered for the first postoperative week.
We have performed this technique in 3 patients who required reconstruction of the PA and in 2 patients who required reconstruction of the SVC for lung cancer infiltration. PA reconstruction was associated to a left upper sleeve lobectomy in 1 patient and to a standard left upper lobectomy in the other 2 patients. In all 3 patients the primary tumor infiltrated the concave surface of the interlobar pulmonary artery and the origin of the upper lobe branches. SVC reconstruction was associated to a right upper sleeve lobectomy in 1 patient and to a standard right upper lobectomy in the other patient. All 5 patients were male with an age range of 5068 years (mean: 62 years). All of the operations were performed through a lateral muscle sparing thoracotomy on the fifth intercostal space. Mean clamping time was 21 minutes (range: 1825) for the PA reconstructive procedures and 23 minutes (range: 2026) for SVC reconstruction. Postoperative in-hospital stay ranged from 57 days (mean: 5.8 days). We observed no intraoperative or postoperative complications related to the reconstructive procedures. The only postoperative complication was a persistent air leak in 1 patient undergoing PA reconstruction associated with left upper lobectomy. The patient was discharged with a Heimlich valve that was removed 1 week later. All the patients are well and without evidence of disease 6 and 12 months postoperatively.
| Comment |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Galetta and L. Spaggiari Reply to the editor. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1601 - 1602. [Full Text] [PDF] |
||||
![]() |
F. Rea, G. Marulli, and F. Sartori Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: Preliminary results J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 592 - 592. [Full Text] [PDF] |
||||
![]() |
L. Spaggiari, F. Leo, G. Veronesi, P. Solli, D. Galetta, B. Tatani, F. Petrella, and D. Radice Superior Vena Cava Resection for Lung and Mediastinal Malignancies: A Single-Center Experience With 70 Cases Ann. Thorac. Surg., January 1, 2007; 83(1): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Andrilli, A. M. Ciccone, M. Ibrahim, F. Venuta, and E. A. Rendina A new technique for prosthetic reconstruction of the superior vena cava J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 192 - 194. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |